NCT05584111View on ClinicalTrials.gov

Oral Administration of STC-15 in Subjects With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

December 22, 2024

Conditions
Advanced CancerAdvanced Solid TumorCancer
Interventions
DRUG

STC-15

STC-15 oral capsules various dosing regimen in 3-week cycles

Trial Locations (3)

77030

The University of Texas MD Anderson Cancer Center, Houston

78229

South Texas Accelerated Research Therapeutics, San Antonio

85258

Honor Health, Scottsdale

All Listed Sponsors
lead

STORM Therapeutics LTD

INDUSTRY